Canaccord Genuity Reaffirms “Buy” Rating for Intuitive Surgical (NASDAQ:ISRG)

Canaccord Genuity reaffirmed their buy rating on shares of Intuitive Surgical (NASDAQ:ISRG) in a report released on Friday morning, BenzingaRatingsTable reports. The brokerage currently has a $610.00 price target on the medical equipment provider’s stock, up from their previous price target of $575.00.

A number of other research firms have also recently issued reports on ISRG. Deutsche Bank initiated coverage on shares of Intuitive Surgical in a research report on Monday, April 1st. They set a buy rating and a $630.00 price objective on the stock. Zacks Investment Research cut shares of GenMark Diagnostics from a hold rating to a sell rating in a research report on Wednesday, April 24th. Cantor Fitzgerald set a $620.00 price objective on shares of Intuitive Surgical and gave the stock a buy rating in a research report on Thursday, April 4th. Piper Jaffray Companies cut shares of Post from an overweight rating to a neutral rating in a research report on Friday. Finally, Citigroup raised shares of China Petroleum & Chemical from a neutral rating to a buy rating in a research report on Tuesday, May 14th. Three investment analysts have rated the stock with a sell rating, three have assigned a hold rating and ten have assigned a buy rating to the stock. The stock currently has an average rating of Hold and an average price target of $576.85.

ISRG stock opened at $528.81 on Friday. The company has a market cap of $61.05 billion, a PE ratio of 55.72, a PEG ratio of 4.61 and a beta of 1.08. The stock’s 50-day moving average is $513.88. Intuitive Surgical has a 1 year low of $430.24 and a 1 year high of $589.32.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $3.25 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.23 by $1.02. The company had revenue of $1.10 billion for the quarter, compared to analysts’ expectations of $1.03 billion. Intuitive Surgical had a net margin of 29.95% and a return on equity of 17.54%. The business’s revenue was up 20.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.76 EPS. On average, research analysts anticipate that Intuitive Surgical will post 9.4 earnings per share for the current fiscal year.

In related news, CEO Gary S. Guthart sold 22,636 shares of the company’s stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $501.48, for a total value of $11,351,501.28. Following the sale, the chief executive officer now owns 386,866 shares in the company, valued at approximately $194,005,561.68. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Salvatore Brogna sold 1,172 shares of the stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $500.60, for a total transaction of $586,703.20. Following the completion of the sale, the chief operating officer now owns 5,933 shares of the company’s stock, valued at approximately $2,970,059.80. The disclosure for this sale can be found here. Insiders sold a total of 27,621 shares of company stock worth $13,828,454 in the last 90 days. 1.70% of the stock is currently owned by company insiders.

A number of large investors have recently bought and sold shares of ISRG. Icon Wealth Partners LLC purchased a new stake in Intuitive Surgical in the 1st quarter valued at about $26,000. Stone House Investment Management LLC purchased a new stake in Intuitive Surgical in the 1st quarter valued at about $31,000. Advisory Alpha LLC purchased a new stake in Intuitive Surgical in the 1st quarter valued at about $32,000. Ellis Investment Partners LLC purchased a new stake in Intuitive Surgical in the 1st quarter valued at about $34,000. Finally, Liberty Wealth Management LLC purchased a new stake in Intuitive Surgical in the 4th quarter valued at about $37,000. Hedge funds and other institutional investors own 85.58% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

See Also: What does a hold rating mean?

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.